Tags : Nestle Skin Health

Pharma

Palette Life Sciences Signs a Worldwide Commercialization and Development Agreement

Shots: Palette to receive global development rights for Nestle’s Deflux, Solesta and Barrigel and will focus on its commercialization. Nestle will continue to develop the license products for Palette The licensed products are developed by using Nestle’s NASHA technology, used for injecting and creating firm gel texture. Additionally, Pharmanest AB will be renamed as Palette […]Read More